Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 21, 1991 - Issue 7
93
Views
11
CrossRef citations to date
0
Altmetric
Original Article

Medicinal azides. Part 8. The in vitro metabolism of p-substituted phenyl azides

, &
Pages 935-943 | Received 13 Sep 1990, Accepted 21 Feb 1991, Published online: 27 Aug 2009

References

  • Baker N. D., Griffin R. J., Irwin W. J., Slack J. A. The reduction of aryl azides by dithiothreitol: a model for bioreduction of aromatic azido-substituted drugs. International Journal of Pharmaceutics 1989; 52: 231–238
  • Bayley H. Photoaffinity labelling and related techniques. Azides and Nitrenes, Reactivity and Utility, E. F.V. Scriven. Academic Press, London 1984; 434–487
  • Bayley H., Standring D. N., Knowles J. R. Propane-1,3-dithiol: selective reagent for the efficient reduction of alkyl and aryl azides to amines. Tetrahedron Letters 1978; 39: 3633–3634
  • Bliss E. A., Brown T. B., Stevens M. F. G., Wong C. K. The biological and chemical properties of 4-azidobenzenesulphonamide (‘azidosulphanilamide’). Journal of Pharmacy and Pharmacology 1979; 31: 66P, (S)
  • Bliss E. A., Griffin R. J., Stevens M. F. G. Structural studies on bioactive compounds. Part 5. Synthesis and properties of 2,4-diaminopyrimidine dihydrofolate reductase inhibitors bearing lipophilic azido groups. Journal of the Chemical Society Perkin Transactions, I 1987; 2217–2227
  • Broll H., Lepore A. M., Tausch G. Double-blind controlled clinical evaluation of effectiveness of zidometacin by oral and rectal route in osteoarthritis. International Clinical and Pharmacological Research 1986; VI(6)489–493
  • Cartwright I. L., Hutchinson D. W., Armstrong V. W. The reaction between thiols and 8-azidoadenosine derivatives. Nucleic Acids Research 1976; 3: 2331–2339
  • Cheng Y., Dutschman G. E., Bastow K. F., Sarngadharan M. G., Ting R. Y. C. Human immunodeficiency virus reverse transcriptase: general properties and its interactions with nucleoside triphosphate analogs. Journal of Biological Chemistry 1987; 262: 2187–2189
  • Cone E. J. The metabolism of azidomorphine in a human subject. Xenobiotica 1978; 8: 301–304
  • Daniel J. W. A soluble aerobic reduced nicotinamide adenine dinucleotide (phosphate) azoreductase. Biochemical Journal 1969; 111: 19P–20P
  • Gibson G. G., Skett P. Introduction to Drug Metabolism. Chapman & Hall, London 1986
  • Handlon A. L., Oppenheimer N. J. Thiol reduction of 3′-azidothymidine to 3′-aminothymidine: kinetic and biochemical implications. Pharmaceutical Research 1988; 5: 297–299
  • Hartree E. F. Determination of protein: a modification of the Lowry method that gives you a linear photometric response. Analytical Biochemistry 1972; 48: 422–427
  • Hunaiti A. A., Abu-Orabi S. T., Sahran M. A. A., Owais W. M. Interaction of organic azides with purified camel glutathione-S-transferase. Biochemical Medicine and Metabolic Biology 1988; 39: 140–147
  • Kamali F., Gescher A., Slack J. A. Medicinal azides. Part 3. The metabolism of the investigational antitumour agent meta-azidopyrimethamine in mouse tissue in vitro. Xenobiotica 1988; 18: 1157–1164
  • Knoll J., Zsilla G., Makleit S. The metabolism of azidomorphine in the rat. Medical Biology 1975; 53: 501–504
  • Lin T. S., Chen M. S., McLaren C., Gao Y. S., Ghazzouli I., Prusoff W. H. Synthesis and antiviral activity of various 3-azido, 3-amino, 2,3-unsaturated, and 2,3-dideoxy analogues of pyrimidine deoxyribonucleosides against retroviruses. Journal of Medicinal Chemistry 1987; 30: 440–444
  • Mason R. P., Peterson F. J., Holtzman J. L. Inhibition of azoreductase by oxygen. The role of the azo anion tree radical metabolite in the reduction of oxygen to superoxide. Molecular Pharmacology 1978; 14: 665–671
  • Mitsuya H., Broder S. Strategies for antiviral therapy in AIDS. Nature 1987; 325: 773–778
  • Owais W. M., Kleinhofs A. Metabolic activation of the mutagen azide in biological systems. Mutation Research 1988; 197: 313–323
  • Resetar A., Spector T. Glucuronidation of 3′-azido-3′-deoxythymidine: human and rat specificity. Biochemical Pharmacology 1989; 38(9)1389–1393
  • Shargel L., Mazel P. Influence of 2,4-dichloro-6-phenoxyethylamine (DPEA1 and β-diethylaminoethyI diphenylpropylacetate (SKF-525A) on hepatic microsomal azoreductase activity from phenobarbitol or 3-methylchalanthrene induced rats. Biochemical Pharmacology 1972; 21: 69–75
  • Shaw A. J., Gescher A., Mraz J. Cytotoxicity and metabolism of the hepatotoxin N-methylformamide and related formamides in mouse hepatocytes. Toxicology and Applied Pharmacology 1988; 95: 162–170
  • Slack J. A., Pashley S. G. H., Stevens M. F. G., Griffin R. J. Analysis and preclinical pharmacology of the new lipophilic DHFR inhibitor MZPES. Proceedings of the American Association for Cancer Research 1986; 27: 403
  • Smith P. A. S., Boyer J. H. Benzofuran oxide II. Decomposition of o-nitrophenyl azide. Organic Syntheses Collective 1963; 4: 75
  • Staros J. V., Bayley H., Standring D. N., Knowles J. R. Reduction of aryl azides by thiols: implications for the use of photoaffinity reagents. Biochemical and Biophysical Research Communications 1978; 80: 568–572
  • Stevens M. F. G., Griffin R. J., Wong S. K. The aromatic azido group in anti-cancer drug design: application in the development of novel lipophilic dihydrofolate reductase inhibitors. Anti-Cancer Drug Design 1987; 2: 311–318
  • Zimmerman T. P., Mahony W. B., Prus K. L. 3′-Azido-3′-deoxythymidine: an unusual nucleoside analogue that permeates the membrane of human erythrocytes and lymphocytes by nonfacilitated diffusion. Journal of Biological Chemistry 1987; 262: 5748–5754

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.